Indication for the prophylactic total gastrectomy in the hereditary diffuse gastric cancer in carriers of E-Cadherin mutation. Two observations

被引:0
|
作者
Godlewski, G. [1 ]
Chiesa, J. [4 ]
Pujol, P. [2 ]
Bourgaud, J. F. [3 ]
Pignodel, C.
Prudhomme, M. [1 ]
机构
[1] CHU, Hop Caremeau, Dept Chirurg Digestive, F-30029 Nimes, France
[2] CHU Montpellier, Hop Arnaud Villeneuve, Serv Genet Med, F-34295 Montpellier, France
[3] CHU, Serv Cytogenet, Nimes, France
[4] CHU, Lab Anatomie Pathol, F-30029 Nimes, France
来源
关键词
Gastric cancer; E; -Cadherin; CDH1; Hereditary diffuse gastric cancer;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim : The germ-line truncating mutation in the E-Cadherin, CDH1, is identified in 30% of hereditary diffuse gastric cancer (CGDH). The tumors are characterized by a high penetrance with an autosomal dominant pattern of inheritance, predominantly in young people. The endoscopic surveillance, by current methods, is largely ineffective because most tumors are growing up diffusely and quickly. We report the outcomes of 2 asymptomatic patients with the CDH1 mutation who have undergone prophylactic total gastrectomy (GTP). Patients and methods: Two brothers 22 and 33 years old, belonging to a family severely altered by CGD, underwent prophylactic total gastrectomy with Roux en Y reconstruction. Results: Pathologic examination of the stomach shows no evidence of in situ or invasive carcinoma despite multiple samples. There were no operative complications. A 5-5 kg weight loss and diarrhea stabilised in a 3 month period. There were no more complications in the long term. Discussion: Four points are discussed: 1/ The preoperative endoscopic screening for visualisation of carcinoma microfoci and of gastric ectopia in oesophagus. 2/ The interest of the chromoendoscopic surveillance unfortunately limited by size of tumoral foci never detectable if inferior to 4mm. 3/ The precision of the surgical procedure needing a complete removal of gastric mucosa that means GTP in every case. 4/ Regular screening for malignancies of other organs related to the CDH1 mutation (breast, colon-rectum, prostate). 5/ A proposition of therapeutic decisions for CGDH. Conclusion. The GTP indication is often difficult to promote for asymptomatic patients, but the operation avoids any risk of gastric cancer. Nevertheless the GTP cannot dispense patients of regular polyvisceral surveillance.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [1] Hereditary diffuse gastric cancer: Pathologic findings from prophylactic gastrectomy in four siblings with a germline E-cadherin mutation.
    Muir, TE
    Donahue, JH
    Lindor, NM
    Chun, YS
    Smyrk, TC
    GASTROENTEROLOGY, 2001, 120 (05) : A742 - A742
  • [2] CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer
    Norton, Jeffrey A.
    Ham, Christine M.
    Van Dam, Jacques
    Jeffrey, R. Brooke
    Longacre, Teri A.
    Huntsman, David G.
    Chun, Nicki
    Kurian, Allison W.
    Ford, James M.
    ANNALS OF SURGERY, 2007, 245 (06) : 873 - 879
  • [3] Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers
    Ithurralde-Argerich, Javier
    Rosner, Laura
    Rizzolo, Mariana
    Faerberg, Alejandro
    Puma, Rolando
    Ferro, Diego
    Duque, Camilo
    Kujaruk, Mirta
    Cuenca-Abente, Federico
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2021, 31 (07): : 729 - 737
  • [4] E-cadherin and hereditary diffuse gastric cancer
    Pedrazzani, Corrado
    Corso, Giovanni
    Marrelli, Daniele
    Roviello, Franco
    SURGERY, 2007, 142 (05) : 645 - 657
  • [5] Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer
    Shepard, Benjamin
    Yoder, Leon
    Holmes, Cynthia
    ACG CASE REPORTS JOURNAL, 2016, 3 (04)
  • [6] Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy
    Inaba, Yasunori
    Goda, Kenichi
    Kondo, Masayuki
    Abe, Keiichiro
    Kanamori, Akira
    Suzuki, Tsunehiro
    Tominaga, Keiichi
    Nakagawa, Masatoshi
    Morita, Shinji
    Kojima, Kazuyuki
    Ishida, Kazuyuki
    Irisawa, Atsushi
    INTERNAL MEDICINE, 2024, 63 (02) : 235 - 239
  • [7] Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families
    Pharoah, PDP
    Guilford, P
    Caldas, C
    GASTROENTEROLOGY, 2001, 121 (06) : 1348 - 1353
  • [8] Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all
    Gaya, Daniel R.
    Stuart, Robert C.
    Going, James J.
    Stanley, Adrian J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (12) : 1249 - 1251
  • [9] Prophylactic gastrectomy for E-Cadherin (CDH1) mutation carriers: Report of a series
    Qureshi, N.
    Whiting, J.
    Hallissey, M.
    Cole, T.
    Mckown, C.
    Gourevitch, D.
    Fielding, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 98 - 98
  • [10] Hereditary diffuse gastric cancer: lifesaving total gastrectomy for CDH1 mutation carriers
    Lynch, Henry T.
    Lynch, Jane F.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 (07) : 433 - 435